FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems – ModernMedicine

Posted: Published on February 18th, 2017

This post was added by Dr. Richardson


CNN
FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems
ModernMedicine
The FDA has approved the drug Emflaza (deflazacort) to treat patients 5 and older with Duchenne muscular dystrophy (DMD). The drug is available as both a tablet and an oral suspension. Although already in use to treat DMD around the world, this is the ...
Families, lawmakers demand transparency for $89000 drugCNN
DMD Access to Deflazacort Will Continue Amid Emflaza ControversyMuscular Dystrophy News
FDA Approves Marathon's $89000 Muscular Dystrophy DrugSci-Tech Today
Life Science Daily -The Pharmaceutical Journal -P&T Community
all 45 news articles »

Go here to see the original:
FDA Approves Drug to Treat Duchenne Muscular Dystrophy, but Congress Has Problems - ModernMedicine

Related Posts
This entry was posted in Muscular Dystrophy Treatment. Bookmark the permalink.

Comments are closed.